Nuvation Bio NUVB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$204.63M+64.0% | -$567.94M-649% | -$75.8M+27.3% | -$104.2M-20.0% | ||
| $1.74M+155% | $683K+208% | $222K+11.6% | $199K+8.2% | ||
| $35.89M+11.2% | $32.28M+65.4% | $19.51M+19.8% | $16.29M+75.8% | ||
| -$173.43M-33.0% | -$130.41M-91.8% | -$68M+29.2% | -$96.11M-40.9% | ||
| $8M— | $0-100% | $69K-81.4% | $370K+31.2% | ||
| —— | $122.7M+1,275% | $8.92M— | —— | ||
| $202.54M— | —— | $628K— | —— | ||
| —— | —— | —— | -$31.32M— | ||
| -$181.43M-39.1% | -$130.41M-91.6% | -$68.07M+29.4% | -$96.48M-40.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.